Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ·Healthcare·Biotechnology
$4.73
-4.64%
Mkt Cap $7.91M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $666.67K | $2.50M | +275.00% | -$4.30 | -$3.84 | +10.70% | — | — |
| Q4 2025 Nov 12, 2025 | $820.80K | $2.17M | +164.25% | -$5.07 | -$3.72 | +26.63% | — | — |
| Q3 2025 Aug 14, 2025 | $845.80K | $1.80M | +113.29% | -$6.40 | -$4.46 | +30.31% | — | — |
| Q2 2025 May 12, 2025 | $767.50K | $1.22M | +59.22% | -$6.80 | -$5.80 | +14.71% | — | — |
| Q1 2025 Mar 24, 2025 | $790.00K | $10.00K | -98.73% | -$7.60 | -$7.60 | +0.00% | — | — |
| Q4 2024 Nov 12, 2024 | $790.00K | $1.14M | +44.43% | -$0.36 | -$0.40 | -11.11% | — | — |
| Q3 2024 Aug 13, 2024 | $890.00K | $1.27M | +43.26% | -$0.54 | -$0.56 | -3.70% | — | — |
| Q2 2024 May 14, 2024 | $2.06M | $5.27M | +156.02% | -$0.51 | -$0.28 | +45.10% | — | — |
| Q1 2024 Mar 21, 2024 | $1.71M | $2.09M | +21.96% | -$0.47 | -$0.47 | +0.00% | — | — |
| Q4 2023 Nov 9, 2023 | $1.77M | $2.53M | +42.82% | -$0.49 | -$0.43 | +12.24% | — | — |
| Q3 2023 Aug 7, 2023 | $1.90M | $1.43M | -24.58% | -$0.53 | -$0.48 | +9.43% | — | — |
| Q2 2023 May 11, 2023 | $1.31M | $1.83M | +39.39% | -$0.49 | -$0.45 | +8.16% | — | — |
| Q1 2023 Mar 29, 2023 | $1.24M | $1.41M | +14.25% | -$0.63 | -$0.53 | +15.87% | — | — |
| Q4 2022 Nov 10, 2022 | $1.23M | $2.11M | +71.71% | -$0.56 | -$0.58 | -3.57% | — | — |
| Q3 2022 Aug 10, 2022 | $500.00K | $1.39M | +178.60% | -$0.68 | -$0.61 | +10.29% | — | — |
| Q2 2022 May 12, 2022 | $500.00K | $813.00K | +62.60% | -$0.71 | -$0.64 | +9.86% | — | — |
| Q1 2022 Mar 30, 2022 | $375.00K | $508.00K | +35.47% | -$0.66 | -$0.73 | -10.61% | — | — |
| Q4 2021 Nov 9, 2021 | $500.00K | $752.00K | +50.40% | -$0.63 | -$0.63 | +0.00% | — | — |
| Q3 2021 Aug 12, 2021 | $3.33M | — | — | -$0.38 | -$0.64 | -68.42% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.64 | -$0.86 | -34.37% | — | — |